Authors:
STOECKEL K
HOFHEINZ W
LANEURY JP
DUCHENE P
SHEDLOFSKY S
BLOUIN RA
Citation: K. Stoeckel et al., STABILITY OF CEPHALOSPORIN PRODRUG ESTERS IN HUMAN INTESTINAL JUICE -IMPLICATIONS FOR ORAL BIOAVAILABILITY, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2602-2606
Citation: Al. Roe et al., CHARACTERIZATION OF NUCLEAR-PROTEIN BINDING (AP-1, GR, AND STAT) IN THE GENETICALLY-OBESE (FA FA) ZUCKER RAT/, Life sciences (1973), 63(15), 1998, pp. 1339-1346
Citation: Al. Roe et al., CONSTITUTIVE AP-1 BINDING-ACTIVITY IN THE GENETICALLY-OBESE (FA FA) ZUCKER RAT/, The FASEB journal, 11(9), 1997, pp. 3053-3053
Authors:
REES WA
HARKINS JD
WOODS WE
BLOUIN RA
LU M
FENGER C
HOLLAND RE
CHAMBERS TM
TOBIN T
Citation: Wa. Rees et al., AMANTADINE AND EQUINE INFLUENZA - PHARMACOLOGY, PHARMACOKINETICS AND NEUROLOGICAL EFFECTS IN THE HORSE, Equine veterinary journal, 29(2), 1997, pp. 104-110
Authors:
SHEDLOFSKY SI
ISRAEL BC
TOSHEVA R
BLOUIN RA
Citation: Si. Shedlofsky et al., ENDOTOXIN DEPRESSES HEPATIC CYTOCHROME P450-MEDIATED DRUG-METABOLISM IN WOMEN, British journal of clinical pharmacology, 43(6), 1997, pp. 627-632
Authors:
CHEN SQ
CHOU WH
BLOUIN RA
MAO ZP
HUMPHRIES LL
MEEK C
NEILL JR
MARTIN WL
HAYS LR
WEDLUND PJ
Citation: Sq. Chen et al., THE CYTOCHROME-P450 2D6 (CYP2D6) ENZYME POLYMORPHISM - SCREENING COSTS AND INFLUENCE ON CLINICAL OUTCOMES IN PSYCHIATRY, Clinical pharmacology and therapeutics, 60(5), 1996, pp. 522-534
Citation: Al. Roe et al., IN-VIVO PHENOBARBITAL TREATMENT INCREASES PROTEIN-BINDING TO A PUTATIVE AP-1 SITE IN THE CYP2B2 PROMOTER, Biochemical and biophysical research communications, 228(1), 1996, pp. 110-114
Authors:
ZANNIKOS PN
BANDYOPADHYAY AM
ROBERTSON LW
BLOUIN RA
Citation: Pn. Zannikos et al., EXPRESSION OF THE CYP3A AND CYP2C11 ENZYMES IN A NUTRITIONALLY OBESE RODENT MODEL - RESPONSE TO PHENOBARBITAL TREATMENT, International journal of obesity, 18(6), 1994, pp. 369-374
Authors:
SHEDLOFSKY SI
KORTAS DY
ISRAEL BC
MA L
MCCLAIN CJ
BLOUIN RA
Citation: Si. Shedlofsky et al., WOMEN VOLUNTEERS GIVEN ENDOTOXIN AS A MODEL OF SEPSIS HAVE LESS INHIBITION THAN MEN OF P450-MEDIATED DRUG-METABOLISM, Hepatology, 20(4), 1994, pp. 10000186-10000186
Authors:
SHEDLOFSKY SI
BLOUIN RA
MCCLAIN CJ
JOHNSON SB
WERMELING DP
Citation: Si. Shedlofsky et al., ANALYSIS OF MEDICATIONS ADMINISTERED TO PATIENTS WITH SEPSIS SYNDROME- LIKELIHOOD OF ADVERSE DRUG-INTERACTIONS, Hepatology, 20(4), 1994, pp. 10000398-10000398
Authors:
ZANNIKOS PN
BANDYOPADHYAY AM
ROBERTSON LW
BLOUIN RA
Citation: Pn. Zannikos et al., CYTOCHROME-P450 2B ENZYME-INDUCTION DEFECT AFTER 2,2',4,4',5,5'-HEXACHLOROBIPHENYL TREATMENT IN THE FA FA ZUCKER RAT/, The Journal of pharmacology and experimental therapeutics, 268(3), 1994, pp. 1565-1570
Authors:
SHEDLOFSKY SI
ISRAEL BC
MCCLAIN CJ
HILL DB
BLOUIN RA
Citation: Si. Shedlofsky et al., ENDOTOXIN ADMINISTRATION TO HUMANS INHIBITS HEPATIC CYTOCHROME P450-MEDIATED DRUG-METABOLISM, The Journal of clinical investigation, 94(6), 1994, pp. 2209-2214
Authors:
BLOUIN RA
MCNAMARA PJ
CHANDLER MHH
KOSTENBAUDER HB
Citation: Ra. Blouin et al., DEVELOPMENT OF A CLINICAL-PHARMACOLOGY GRADUATE PROGRAM AT THE UNIVERSITY-OF-KENTUCKY, American journal of pharmaceutical education, 58(3), 1994, pp. 289-293
Authors:
ISRAEL BC
BLOUIN RA
MCINTYRE W
SHEDLOFSKY SI
Citation: Bc. Israel et al., EFFECTS OF INTERFERON-ALPHA MONOTHERAPY ON HEPATIC DRUG-METABOLISM INCANCER-PATIENTS, British journal of clinical pharmacology, 36(3), 1993, pp. 229-235
Authors:
SHEDLOFSKY SI
ISRAEL BC
SWIM AT
DENISON MG
HILL DB
MCCLAIN CJ
BLOUIN RA
Citation: Si. Shedlofsky et al., DECREASED HEPATIC P450-MEDIATED DRUG CLEARANCES IN HUMANS GIVEN ENDOTOXIN (LPS) AS A MODEL OF GRAM-NEGATIVE SEPSIS, Hepatology, 18(4), 1993, pp. 10000129-10000129
Authors:
TOLER SM
YOUNG AB
MCCLAIN CJ
SHEDLOFSKY SI
BANDYOPADHYAY AM
BLOUIN RA
Citation: Sm. Toler et al., HEAD-INJURY AND CYTOCHROME-P-450 ENZYMES - DIFFERENTIAL EFFECT ON MESSENGER-RNA AND PROTEIN EXPRESSION IN THE FISCHER-344 RAT, Drug metabolism and disposition, 21(6), 1993, pp. 1064-1069
Authors:
ZANNIKOS PN
BANDYOPADHYAY AM
ROBERTSON LW
BLOUIN RA
Citation: Pn. Zannikos et al., EFFECT OF NUTRITIONAL OBESITY ON THE INDUCTION OF CYP2B ENZYMES FOLLOWING PHENOBARBITAL TREATMENT, Drug metabolism and disposition, 21(5), 1993, pp. 782-787
Authors:
TUNTATERDTUM S
CHAUDHARY IP
CIBULL M
ROBERTSON LW
BLOUIN RA
Citation: S. Tuntaterdtum et al., ACETAMINOPHEN HEPATOTOXICITY - INFLUENCE OF PHENOBARBITAL AND BETA-NAPHTHOFLAVONE TREATMENT IN OBESE AND LEAN ZUCKER RATS, Toxicology and applied pharmacology, 123(2), 1993, pp. 219-225
Authors:
CHAUDHARY IP
TUNTATERDTUM S
MCNAMARA PJ
ROBERTSON LW
BLOUIN RA
Citation: Ip. Chaudhary et al., EFFECT OF GENETIC OBESITY AND PHENOBARBITAL TREATMENT ON THE HEPATIC CONJUGATION PATHWAYS, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1333-1338
Authors:
BANDYOPADHYAY AM
CHAUDHARY I
ROBERTSON LW
GEMZIK B
PARKINSON A
BLOUIN RA
Citation: Am. Bandyopadhyay et al., EXPRESSION OF A MALE-SPECIFIC CYTOCHROME-P450 ISOZYME (CYP2C11) IN FAFA ZUCKER RATS - EFFECT OF PHENOBARBITAL TREATMENT/, Archives of biochemistry and biophysics, 307(2), 1993, pp. 386-390
Authors:
BLOUIN RA
BANDYOPADHYAY AM
CHAUDHARY I
ROBERTSON LW
GEMZIK B
PARKINSON A
Citation: Ra. Blouin et al., CYTOCHROME-P450-2B ENZYME (CYP2B) INDUCTION DEFECT FOLLOWING PHENOBARBITAL TREATMENT IN THE FA FA ZUCKER RAT - MOLECULAR CHARACTERIZATION/, Archives of biochemistry and biophysics, 303(2), 1993, pp. 313-320